ANTHERA PHARMACEUTICALS
Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome a... ssociated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.
ANTHERA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.anthera.com
Total Employee:
11+
Status:
Active
Contact:
510-856-5600
Email Addresses:
[email protected]
Total Funding:
101.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Anthera Pharmaceuticals
OrbiMed
OrbiMed investment in Post-IPO Equity - Anthera Pharmaceuticals
Caxton Associates
Caxton Associates investment in Post-IPO Equity - Anthera Pharmaceuticals
Mitsubishi International Corporation (MIC)
Mitsubishi International Corporation (MIC) investment in Venture Round - Anthera Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - Anthera Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Anthera Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Venture Round - Anthera Pharmaceuticals
Caxton Advantage Life Sciences Fund
Caxton Advantage Life Sciences Fund investment in Venture Round - Anthera Pharmaceuticals
VantagePoint Capital Partners
VantagePoint Capital Partners investment in Venture Round - Anthera Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Anthera Pharmaceuticals
Official Site Inspections
http://www.anthera.com
- Host name: h7.hostdl.com
- IP address: 148.251.116.174
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
